Global Point Of Care Infection Control Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In October 2020, Cepheid launched the Xpert Xpress SARS-CoV-2/Flu/RSV Test, a rapid point-of-care test that can detect SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in under 30 minutes. This multi-pathogen testing capability enhances infection control efforts by allowing healthcare providers to quickly identify and manage viral respiratory infections, improving patient outcomes and reducing transmission risks.

• In December 2020, Quidel received FDA emergency use authorization for the Sofia 2 SARS Antigen Fluorescent Immunoassay. This point-of-care test provides rapid results for SARS-CoV-2 detection, helping healthcare providers implement timely infection control measures, especially in emergency settings.

By Product Type, the market is divided into Germicidal Wipes, Effervescent Disinfectant Sanitizer Tablets, Hand Hygiene products, and Others. Germicidal wipes are widely used across healthcare settings due to their convenience and effectiveness in eliminating a broad spectrum of pathogens. These wipes are commonly used for disinfecting surfaces, medical equipment, and hands to prevent cross-contamination. The demand for these wipes is growing due to the increasing emphasis on hygiene and infection control in both clinical and non-clinical settings. The ease of use, portability, and quick action of germicidal wipes make them a preferred choice in hospitals, clinics, and homecare settings.

Effervescent disinfectant sanitizer tablets have gained popularity in the infection control market for their ability to be easily dissolved in water to create a disinfectant solution. These tablets are especially useful in environments where traditional liquid disinfectants might be difficult to store or handle. They are commonly used in surface disinfection, cleaning medical equipment, and sanitizing hands. As they offer an environmentally friendly, cost-effective, and highly efficient solution, their adoption is expected to grow, especially in settings with high disinfection needs.

Hand hygiene products, including hand sanitizers, soaps, and antimicrobial gels, play a critical role in infection control, particularly in preventing the transmission of infectious agents between patients and healthcare providers. The use of alcohol-based hand sanitizers has increased significantly, driven by the growing awareness of the importance of hand hygiene in preventing healthcare-associated infections (HAIs). This segment is expanding due to continued education on proper hand hygiene and the growing implementation of strict hygiene protocols in hospitals and clinics.

Others category includes products like disinfectant sprays, surface disinfectants, and antimicrobial clothing. These products complement the primary infection control solutions and provide additional layers of protection. As the need for comprehensive infection control measures rises, products in this category are gaining importance in preventing outbreaks in both healthcare and non-healthcare settings.

By End User, the market is segmented into Hospitals, Clinics, Homecare Settings, and Ambulatory Surgery Centers (ASCs).Hospitals are the largest end users of point-of-care infection control products due to the high risk of infections in clinical environments. Infection control is critical in hospitals, especially in intensive care units (ICUs), emergency departments, and surgical settings where patients are most vulnerable. The rising incidence of healthcare-associated infections (HAIs) and the need for strict hygiene protocols drive the demand for infection control products in hospitals. Hospitals are also major consumers of hand hygiene products, germicidal wipes, and disinfectants to mitigate infection risks.

Clinics, which provide outpatient care, also represent a significant market segment. While infection control in clinics is less intensive than in hospitals, the need to prevent the spread of infections is equally critical, particularly in dental clinics, pediatric centers, and general practitioner offices. Clinics are increasingly adopting hand sanitizers, disinfectant wipes, and surface cleaning products to maintain a safe environment for patients and healthcare workers.

Homecare Settings The demand for infection control products in homecare settings has risen due to the growing trend of patients receiving medical care at home, especially the elderly or chronically ill. Products like hand sanitizers, disinfectant wipes, and surface cleaners are essential in homecare settings to prevent the spread of infections and ensure the safety of both patients and caregivers. With the increasing prevalence of home healthcare and the aging population, this segment is expected to grow substantially.

ASCs are specialized healthcare facilities that provide outpatient surgeries, and infection control is critical to prevent surgical site infections (SSIs). Due to their focus on patient safety and cleanliness, ASCs use a wide range of infection control products, including hand hygiene products, disinfectant wipes, and surface disinfectants. The rising number of outpatient procedures performed at ASCs contributes to the growth of this segment as the need for infection prevention measures in these settings intensifies.

Global Point Of Care Infection Control Segment Analysis

In this report, the Global Point Of Care Infection Control Market has been segmented by Product Type, End User and Geography.

Global Point Of Care Infection Control Market, Segmentation by Product Type

The Global Point Of Care Infection Control Market has been segmented by Product Type into Germicidal Wipes, Effervescent Disinfectant Sanitizer Tablets, Hand Hygiene and Others.

Germicidal wipes are one of the most widely used infection control products in healthcare settings. These disposable wipes are pre-saturated with disinfectant solutions and are used to quickly disinfect surfaces, medical equipment, and hands. They are valued for their portability, convenience, and ability to kill a broad spectrum of harmful pathogens, including bacteria, viruses, and fungi. Due to the growing emphasis on maintaining hygiene and reducing cross-contamination in healthcare environments, the demand for germicidal wipes has significantly increased.

Effervescent disinfectant sanitizer tablets are gaining popularity due to their ease of use and effectiveness. These tablets dissolve in water to create a disinfecting solution, which can be used for cleaning surfaces, medical instruments, and other equipment. Their compact form, long shelf-life, and environmentally friendly nature make them an attractive option for infection control, particularly in resource-limited environments where space and storage options are restricted.

Hand hygiene products, including hand sanitizers, soaps, and antimicrobial gels, are critical components of infection control, especially in healthcare environments where the spread of infections is a constant concern. Hand sanitizers, particularly alcohol-based formulations, are highly effective in reducing the transmission of pathogens and are commonly used by healthcare professionals, patients, and visitors in hospitals, clinics, and other settings. The increasing awareness of hygiene practices, along with strict hospital protocols, is contributing to the growth of this segment.

Others category includes a range of infection control products that complement the primary options mentioned above. These may include surface disinfectants, antimicrobial sprays, disposable gloves, and protective equipment. Products in this category are vital in ensuring comprehensive infection control across healthcare settings, from waiting rooms to patient rooms and operating theaters. With increasing concerns about infection outbreaks, this segment is seeing higher adoption as part of a more holistic approach to infection prevention.

Global Point Of Care Infection Control Market, Segmentation by End User

The Global Point Of Care Infection Control Market has been segmented by End User into Hospitals, Clinics, Homecare Settings and Ambulatory Surgery Centers.

Hospitals are the largest end-users of point-of-care infection control products due to the high risk of infections in clinical environments. Hospitals, especially those with intensive care units (ICUs), emergency departments, and surgical settings, require strict infection control protocols to minimize healthcare-associated infections (HAIs) and ensure patient safety. Infection control products like germicidal wipes, hand hygiene solutions, disinfectant tablets, and surface disinfectants are widely used across various departments within hospitals to prevent the spread of pathogens. Hospitals are also adopting advanced technologies for infection monitoring and prevention, contributing to the high demand for infection control solutions in this setting.

Clinics represent a significant portion of the end-user market for point-of-care infection control products, albeit with a lower level of infection risk compared to hospitals. Clinics, particularly general practitioner offices, dental clinics, and pediatric centers, still face the need for effective infection control to prevent cross-contamination and protect both patients and healthcare providers. Hand hygiene products, surface disinfectants, and germicidal wipes are commonly used in these settings. As clinics are increasingly adopting infection prevention measures and protocols, the demand for point-of-care infection control products is expected to rise.

With the growing trend of home healthcare, especially for elderly and chronic disease patients, homecare settings are becoming increasingly important in the point-of-care infection control market. Products like hand sanitizers, disinfectant wipes, and surface cleaners are essential for ensuring that infection control measures are followed in home environments. Caregivers and patients are using these products to maintain hygiene and prevent infections, particularly in homes where healthcare needs are complex, and multiple individuals may be at risk. The aging population and the shift towards home-based care are expected to drive further demand in this segment.

ASCs, which provide outpatient surgical procedures, require stringent infection control practices to prevent surgical site infections (SSIs) and protect patient health. In these centers, infection control solutions such as hand hygiene products, disinfectant wipes, and surface disinfectants are critical in maintaining a sterile environment. The increasing number of outpatient surgeries, along with a growing emphasis on patient safety and infection prevention, is contributing to the expansion of this market segment. ASCs are adopting infection control measures similar to those in hospitals, but tailored to outpatient settings.

Global Point Of Care Infection Control Market, Segmentation by Geography

In this report, the Global Point Of Care Infection Control Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Point Of Care Infection Control Market Share (%), by Geographical Region, 2024

North America: North America holds a significant share of the point of care infection control market, driven by well-established healthcare infrastructure, a high standard of infection prevention protocols, and increased awareness of the importance of infection control in healthcare settings. The U.S. and Canada are key contributors to this market, where there is a strong emphasis on reducing healthcare-associated infections (HAIs) and ensuring patient safety through stringent hygiene and disinfection practices. The region also benefits from a high adoption rate of advanced infection control products, including hand hygiene solutions, germicidal wipes, and surface disinfectants. Furthermore, the ongoing efforts to address the COVID-19 pandemic have increased the demand for rapid point-of-care diagnostics and infection control solutions in the region.

Europe is another significant market for point of care infection control, with countries like Germany, the U.K., France, and Italy leading in demand for infection control solutions. The region benefits from strong regulatory frameworks governing infection prevention, along with rising concerns about healthcare-associated infections, antibiotic resistance, and patient safety. European healthcare systems emphasize infection control, particularly in hospitals and clinics, driving the adoption of products like disinfectants, hand sanitizers, and surface cleaning solutions. Moreover, the increasing number of outpatient surgeries and the growing elderly population further contribute to the market’s growth in this region.

The Asia Pacific region is expected to witness rapid growth in the point of care infection control market. Countries such as China, India, Japan, and Australia are seeing increased investments in healthcare infrastructure, leading to greater demand for infection control solutions. With the rising burden of infectious diseases, growing healthcare expenditures, and a larger patient population, the adoption of point-of-care infection control products is on the rise. Additionally, the growing awareness of infection prevention, the aging population, and expanding healthcare access in emerging markets like India and Southeast Asia further drive the demand for these products. The shift towards home healthcare and outpatient settings in Asia Pacific is also expected to contribute significantly to market growth.

The Middle East and Africa represent a relatively smaller but steadily growing market for point of care infection control products. The demand in this region is primarily driven by the increasing need for advanced healthcare facilities, rising awareness of infection control practices, and government initiatives to combat infectious diseases. Countries like the UAE, Saudi Arabia, and South Africa are investing heavily in healthcare infrastructure and infection prevention programs. However, challenges such as limited healthcare budgets in some areas and inadequate healthcare infrastructure in certain African countries may hinder growth to some extent. Despite these challenges, the market is expected to grow due to rising healthcare access, particularly in urban centers.

Latin America is another emerging market for point of care infection control solutions, with countries like Brazil, Mexico, and Argentina leading the demand. The region is witnessing increased healthcare investments and a rising focus on improving infection prevention measures to reduce the incidence of healthcare-associated infections. The growing prevalence of chronic diseases, expanding healthcare access, and the need for infection control in both hospital and homecare settings are factors driving market growth. However, some challenges remain, including disparities in healthcare access, limited healthcare budgets, and the need for better regulatory standards in some Latin American countries. Despite these challenges, the market is expected to grow steadily over the forecast period.

This report provides an in depth analysis of various factors that impact the dynamics of Global Point Of Care Infection Control Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Rising Incidence of Infectious Diseases
• Growing Need for Rapid Diagnostics

• Technological Advancements -Technological advancements play a pivotal role in driving the growth of the global point of care infection control market. The continuous innovation in medical technologies and infection control solutions has significantly enhanced the effectiveness, convenience, and efficiency of infection prevention measures across healthcare settings. The development of advanced hand hygiene products, such as alcohol-based hand sanitizers with improved formulations, has made it easier for healthcare professionals to maintain proper hygiene in high-pressure environments. In addition, the introduction of more efficient and user-friendly germicidal wipes, disinfectants, and effervescent disinfectant tablets has contributed to improved surface decontamination and infection prevention in hospitals, clinics, and other healthcare facilities.

  Technological advancements in digital health have also led to the introduction of smart infection control solutions, such as electronic hand hygiene monitoring systems, which track and report compliance in real-time, helping healthcare institutions ensure adherence to hygiene protocols. Moreover, innovations in sterilization equipment and automated disinfection devices, such as UV-C light disinfection units and robotic cleaning systems, are revolutionizing the way hospitals and clinics maintain sterile environments. These devices reduce human error and enhance the efficiency of infection control procedures.

  The integration of technology in infection control extends to homecare settings as well, where devices such as smart disinfectant dispensers and wearable hygiene sensors are gaining popularity. These innovations not only improve the ease of use but also enhance the overall effectiveness of infection prevention measures.

  As healthcare providers increasingly adopt these advanced technologies to combat infections, the point of care infection control market is expected to grow significantly. The ongoing technological improvements contribute to the development of more efficient, cost-effective, and environmentally friendly solutions, thus fueling the demand for infection control products and services across various healthcare settings.

Restraints:

• High Initial Cost of Point-of-Care Devices
• Regulatory Challenges

• Limited Awareness in Emerging Markets -Limited awareness in emerging markets presents a significant restraint for the global point of care infection control market. In many developing countries, there is still a lack of understanding about the importance of infection control and the potential risks associated with healthcare-associated infections (HAIs). This limited awareness can result in suboptimal implementation of infection prevention measures, such as proper hand hygiene, surface disinfection, and the use of protective equipment in healthcare settings. Additionally, there is often inadequate training among healthcare workers regarding infection control protocols, which can further contribute to the spread of infectious diseases in hospitals, clinics, and other healthcare facilities.

  In some regions, particularly in rural or underserved areas, the lack of access to information and education about infection prevention can hinder the widespread adoption of point of care infection control products. The cultural, economic, and infrastructural challenges in these regions further complicate the issue, as many healthcare facilities may not prioritize infection control due to limited resources. This can lead to ineffective infection control practices, ultimately affecting patient safety and increasing the risk of infections.

  The limited availability of high-quality infection control products in emerging markets, combined with the lack of awareness about their benefits, can slow down market growth. The affordability of infection control solutions is another key challenge, as many point of care infection control products may be considered expensive, especially in low-income regions where budget constraints are common.

  Despite these challenges, efforts to increase awareness, educate healthcare workers, and improve infection control practices are gradually growing in emerging markets. However, the overall pace of adoption remains slow, making limited awareness a critical restraint to the growth of the point of care infection control market in these regions.

Opportunities:

• Expansion into Emerging Markets
• Integration with Telehealth Platforms

• Development of Advanced POC Technologies -The development of advanced point-of-care (POC) technologies presents a significant opportunity for the global point of care infection control market. As healthcare systems increasingly demand quicker, more accurate, and efficient solutions to control infections, advancements in POC technologies offer the potential to revolutionize infection prevention and management. These technologies enable healthcare providers to perform rapid diagnostics and monitoring at the site of patient care, leading to quicker identification of infections and more timely interventions. For instance, the integration of molecular diagnostics, such as PCR-based tests, into point-of-care settings can allow for faster detection of pathogens, facilitating the immediate implementation of infection control measures.

  The advancement of digital health solutions, including connected devices and smart sensors, presents new avenues for infection control. Wearable sensors, for example, can monitor hygiene compliance in real-time, ensuring that healthcare workers and patients follow proper infection control protocols. Additionally, the rise of artificial intelligence (AI) and machine learning (ML) in POC technologies can help predict infection outbreaks and monitor infection control measures by analyzing large volumes of healthcare data. These technologies enhance the accuracy and efficiency of infection control, which is critical in preventing healthcare-associated infections (HAIs).

  The development of user-friendly and cost-effective POC devices tailored for healthcare settings, especially in resource-limited areas, presents an opportunity to expand the reach of infection control solutions globally. With better diagnostics and real-time monitoring, healthcare providers can enhance infection control measures, reduce the burden on hospitals, and improve patient outcomes. As the demand for faster, more efficient infection control continues to rise, these advanced POC technologies are poised to play a critical role in shaping the future of infection prevention across various healthcare settings.